Dr. Stephen D. Aradi, MD

Dr. Aradi practices at USFCenter for Advanced Healthcare in Tampa, Florida.

Dr. Aradi's NPI, 1518352996, was assigned on April 1, 2015. Dr. Aradi graduated from USF Health Morsani College of Medicine in 2015. Dr. Aradi holds Florida license ME140217.

Dr. Aradi's primary practice is USFCenter for Advanced Healthcare, at 13330 Usf Laurel Dr, Tampa, FL 33612 in Hillsborough County. The practice phone is (813) 974-2201.

Dr. Aradi's primary practice is USFCenter for Advanced Healthcare in Tampa, Florida. Dr. Aradi is also affiliated with Tampa General Hospital. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Aradi to 5 more hospitals, 2 home health agencies, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Aradi practices, 9 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Aradi's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Aradi is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Aradi's licenses on file in 2 states: Florida and Pennsylvania.

Dmand AI lists epilepsy, essential tremor, fibromyalgia and chronic pain, neuropathy, non-alzheimer's dementia (chronic), parkinson's disease and restless legs syndrome among the conditions Dr. Aradi treats.

CMS data shows 8,919 Medicare services from Dr. Aradi across 10 procedure codes in 2024, for 288 Medicare patients. Medicare paid $75,953 for them. Every service was in an office.

CMS counts 288 Medicare patients who saw Dr. Aradi in 2024. The largest group is 75 to 84, with 111 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Aradi's median patient age at 70, with 55% women.

In 2024, Dr. Aradi wrote 2,960 Medicare Part D claims for 366 patients. 85% of them were for generic drugs. CMS names the drug for 2,784 of them, across 53 drugs with 11 or more claims each, at $1,851,450 in total drug cost. In 2023, CMS named 1,939 claims across 44 drugs.

Dr. Aradi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Aradi as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 12 papers to Dr. Aradi, published from 2017 to 2024. 2020 was the busiest year, with 2. The most frequent topics are Parkinson Disease, Adenosine and Antiparkinson Agents. Dr. Aradi has published most often in Expert Rev Neurother. Dr. Aradi's most frequent co-authors are Robert A. Hauser, MD, Rizwan Akhtar, MD and Steven Nicholas Baldassano, MD.

Dmand AI links Dr. Aradi to 9 clinical trials, 3 of them phase 3 studies. 4 are still active or recruiting. Conditions studied include Chorea, Huntington Disease and Parkinson Disease. Hoffmann-La Roche sponsors the most, 3.

CMS Open Payments shows 14 general payments to Dr. Aradi from 4 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Genentech, Inc. paid the most, $386.

Dmand AI lists 2 awards for Dr. Aradi, most recently Steven L. Galetta Resident Teaching Award in 2019.

Dr. Aradi graduated from USF Health Morsani College of Medicine in 2015. Dr. Aradi is a member of AAN, Huntington Study Group and International Parkinson and Movement Disorder Society.

Dr. Aradi is in network with 18 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.